Table 4.
Odds Ratios for Overall Disease Control (Unadjusted and Adjusted) and Respective 95% Confidence Intervals
Variable | Unadjusted OR (95% CI) | Adjusted* OR (95% CI) |
---|---|---|
Number of days with SABA use in the previous 4 weeks | ||
≤ 8 days | – | – |
> 8 days | 2.9 (1.5–5.6) | 2.6 (1.3–5.2) |
History of exacerbations requiring OCS prescription for at least 3 days, in the last 12 months | ||
No | – | – |
Yes | 3.2 (1.5–6.6) | 3.0 (1.3–6.6) |
Notes: *Adjusted for sociodemographic variables, BMI, smoking history, therapeutic regimen, comorbidities, number of packages purchased in the last 3 months, average number of SABA uses per day, maximum number of SABA uses in a 24-hour period, medical specialty of asthma-related doctors’ appointments, history of exacerbation ED visit in the previous 12 months or requiring hospital admission for at least one night in the previous 12 months.
Abbreviations: OCS, oral corticosteroid; SABA, Short-acting β2-agonists.